Trial Evaluates Treatments for Aphakia in Infants Publish date: Jan 15, 2010 ![]() FRIDAY, Jan. 15 (HealthDay News) -- A randomized trial is examining the benefit of intraocular lens (IOL) implantation
during cataract removal, or contact lenses after surgery, in infants younger than 6 months old, according to a study in the
January issue of the Archives of Ophthalmology. Scott R. Lambert, M.D., from Emory University in Atlanta, and colleagues randomly assigned 114 infants with unilateral
congenital cataracts to cataract surgery with or without IOL implantation. Children who received an IOL had their residual
refractive error corrected with glasses, while children who did not receive an IOL were treated with a contact lens. The researchers note that while the median age at enrollment was 1.8 months, 50 children were 4 to 6 weeks old, 32 were
7 weeks to 3 months old, and the remaining 32 were 3 to 7 months old. On average, eyes with cataracts had shorter axial lengths
and steeper corneas than the fellow eyes. The authors plan to determine grating acuity when the children are 12 months old,
and HOTV visual acuity when the children are 4.5 years old. "The optimal optical treatment of aphakia in infants is unknown," the authors write. "We believe that the Infant Aphakia
Treatment Study, a multicenter, randomized, controlled clinical trial, will clarify whether IOL or contact lens treatment
is associated with better visual outcomes after the surgical extraction of a unilateral congenital cataract during the first
6 months of life." Copyright © 2010 ScoutNews, LLC. All rights reserved. | Coding Counselor Simple and accurate ICD-9 code search. Start Here Patient Education Print customized patient education handouts. Start Here Dermatology Diagnosis Identify skin diseases by age, gender, location. Start Here AHRQ Clinical Guidelines Objective findings on medical interventions. Start Here ![]() ![]()
|